Pharma Journalist -

Johnson & Johnson announced the European Commission (EC), acting on behalf of the European Union (EU) Member States, has approved an Advance Purchase Agreement in which the Janssen…
Read More...

Takeda Pharmaceutical Company Limited and Arrowhead Pharmaceuticals Inc. announced a collaboration and licensing agreement to develop ARO-AAT, a Phase 2 investigational RNA interference…
Read More...

Pfizer Inc. and Sangamo Therapeutics, Inc. a genomic medicines company, today announced that the first participant has been dosed in the Phase 3 AFFINE study of giroctocogene…
Read More...

OliX Pharmaceuticals announced a collaboration with Théa Open Innovation, a sister company of Laboratoires Théa S.A.S ("Théa"), the leading independent pharmaceutical company in Europe …
Read More...

Citius Pharmaceuticals, Inc. a specialty pharmaceutical company developing and commercializing critical care drug products, announced that it has signed an exclusive agreement with…
Read More...

Vir Biotechnology, Inc. and GlaxoSmithKline plc announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial - Intent to Care Early) study…
Read More...

Oragenics, Inc. announced receipt of feedback to its Type B Pre-IND Meeting Request from the U.S. Food and Drug Administration (“FDA”) that it is in broad agreement with the Company’s…
Read More...

Pfizer Inc. and BioNTech SE announced the initiation of a rolling submission to the European Medicines Agency (EMA) for BNT162b2, the lead candidate from the companies’ vaccine…
Read More...

SMi Group are delighted to announce their 12th annual conference RNA Therapeutics, taking place on 10th - 11th February 2021 at the Copthorne Tara Hotel, London, UK. The 2021…
Read More...

SMi Reports: An exclusive interview with María José López Barragán, Founder, Barragan BioConsulting, formerly CMC Product Quality Reviewer, FDA, who will be speaking at the 3rd Annual…
Read More...